Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Gross Profit (2016 - 2025)

Historic Gross Profit for Niagen Bioscience (NAGE) over the last 17 years, with Q3 2025 value amounting to $21.9 million.

  • Niagen Bioscience's Gross Profit rose 3502.46% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.7 million, marking a year-over-year increase of 4146.58%. This contributed to the annual value of $61.6 million for FY2024, which is 2128.0% up from last year.
  • Niagen Bioscience's Gross Profit amounted to $21.9 million in Q3 2025, which was up 3502.46% from $20.2 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Gross Profit ranged from a high of $21.9 million in Q3 2025 and a low of $9.2 million during Q1 2021
  • For the 5-year period, Niagen Bioscience's Gross Profit averaged around $13.6 million, with its median value being $12.4 million (2023).
  • Its Gross Profit has fluctuated over the past 5 years, first crashed by 710.45% in 2022, then surged by 4771.05% in 2025.
  • Niagen Bioscience's Gross Profit (Quarter) stood at $10.9 million in 2021, then grew by 10.56% to $12.0 million in 2022, then increased by 7.66% to $12.9 million in 2023, then surged by 40.66% to $18.2 million in 2024, then rose by 20.5% to $21.9 million in 2025.
  • Its Gross Profit stands at $21.9 million for Q3 2025, versus $20.2 million for Q2 2025 and $19.3 million for Q1 2025.